AI drug discovery is moving beyond prediction to closed-loop execution.
 
Ainotype, Synbio Technologies’ AIDD platform, bridges this gap. Backed by 13 years of molecular manufacturing experience, we provide integrated wet-lab validation and data feedback for AI-designed antibodies, proteins, RNA, and other biologics.
 
How we help AI-driven discovery teams accelerate the DBTL cycle:

 
We’re launching the AIDD Strategic Partnership Program to help AI biology companies connect computational design with experimental validation and actionable data feedback.
 
Explore how Ainotype can connect AI-driven design with wet-lab validation and data feedback to accelerate biologics discovery.

 
Contact Us

Looking for more? These services might be just what you need:
RNA Synthesis Oligo Synthesis DNA Synthesis
 
 
Synbio Technologies LinkedIn X Facebook Facebook

Thank you for connecting with us! Click "Subscribe" to receive valuable insights and news. If you prefer not to receive further emails, just hit "Unsubscribe" — your choice is always respected.
Synbio Technologies LLC
9 Deer Prk Dr., Suite J-25, Monmouth Junction, NJ 08852, USA